close

Enter

Log in using OpenID

Deep Brain Stimulation Devices Market

embed
Deep brain stimulation (DBS) surgery is performed as part of the treatment of various neural debilitating conditions such as Parkinson’s disease (PD), dementia, and Alzheimer’s disease.
Deep Brain Stimulation Devices Market - Size,
Share, Growth, Outlook, and Opportunity
Analysis, 2018-2026
Deep brain stimulation (DBS) surgery is performed as part of the treatment of various neural
debilitating conditions such as Parkinson’s disease (PD), dementia, and Alzheimer’s disease. A
patient fitted with a DBS device can get long-term relief from debilitating symptoms of PD. Although
some patients may require medications post-surgery, there is significant reduction in side-effects
caused due to medications, owing to use of DBS devices. A DBS device is mainly placed in one of
the three U.S. Food and Drug Administration (FDA) approved target sites in PD. Most commonly
preferred target sites are the Globus Pallidus Interna (GPi) and Subthalamic Nucleus (STN).
Request Sample Copy of Research Report:
https://www.coherentmarketinsights.com/insight/request-sample/84
Deep brain stimulation (DBS) device, often described as brain pacemaker, aids in alleviating
symptoms of Parkinson’s disease (PD). The device is implanted at one of the three U.S. Food and
Drug Administration (FDA) approved brain sites to block the electrical signals from these sites to the
brain. The three U.S. FDA approved targeted brain sites are ventrointermedialis (VIM) nucleus of the
thalamus, subthalamic nucleus (STN), and globus pallidus pars interna (GPi). DBS surgery is
performed on patients suffering from PD for at least four years and are on medications albeit with
motor complications.
Frequent approval and Launch of novel devices is expected to fuel the global deep
brain stimulation devices market growth
Key players in the market are focused on approval and launch of novel DBS devices to expand
their product portfolio, which is expected to boost the market growth. For instance, in January
2019, Boston Scientific Corporation launched two new DBS devices namely the Vercise Primary
Cell (PC) and Vercise Gevia Deep Brain Stimulation (DBS) systems.
In June 2015, the U.S. Food and Drug Administration (FDA) approved St. Jude Medical’s Brio
Neurostimulation System, a DBS device that helps to reduce symptoms of Parkinson’s disease
(PD) and essential tremor. Launch and approval of such novel devices is expected to significantly
support the global deep brain stimulation devices market growth over the forecast period.
Report includes chapters which deeply display the following deliverable about industry :
• Deep Brain Stimulation Devices Market Research Objective and Assumption
• Deep Brain Stimulation Devices Market Purview - Report Description, Executive Summary, and
Coherent Opportunity Map (COM)
• Deep Brain Stimulation Devices Market Dynamics, Regulations, and Trends Analysis - Market
Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system
Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global Deep Brain Stimulation Devices Market, By Regions
• Deep Brain Stimulation Devices Market Competition by Manufacturers including Production, Share,
Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type.
• Deep Brain Stimulation Devices Market Manufacturers Profiles/Analysis including Company Basic
Information, Manufacturing Base and Its Competitors.
• Deep Brain Stimulation Devices Market Manufacturing Cost Analysis including Key Raw Materials
and Key Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market Positioning
and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Deep Brain Stimulation Devices Market Forecast including Production, Consumption, Import and
Export Forecast by Type, Applications and Region.
• Research Findings and Conclusion
Key players operating in the global deep brain stimulation devices market include,
Boston Scientific Corporation, Medtronic, Inc., St. Jude Medical, Inc. (Abbott
Laboratories), Cyberonics, Inc., Neuronetics, and Aleva Neurotherapeutics SA.
Inquire Here Before Purchase:
https://www.coherentmarketinsights.com/insight/talk-to-analyst/84
Detailed Segmentation:
• Global Deep Brain Stimulation Devices Market, By Application:
• Parkinson's Disease
• Essential Tremor
• Dystonia
• Others
• Global Deep Brain Stimulation Devices Market, By End User:
• Hospital & Clinics
• Ambulatory Surgical Centers
• Others
• Global Deep Brain Stimulation Devices Market, By Region:
• North AmericaEurope
• Asia Pacific
• Latin America
• Middle East
• Africa
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering action-ready
syndicated research reports, custom market analysis, consulting services, and competitive analysis
through various recommendations related to emerging market trends, technologies, and potential
absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]
Author
38   documents Email
Document
Category
Health and Medicine
Views
2
File Size
154 KB
Tags
brain
1/--pages
Report inappropriate content